Lv31
290 积分 2025-03-05 加入
Shenqi compound ameliorates renal fibrosis in diabetic kidney disease by inhibiting LRG1/TGF-β/Smad signaling pathway
28天前
已完结
Serum interleukin-6 levels predict kidney disease progression in diabetic nephropathy
1个月前
已完结
Next-generation therapeutics for diabetic kidney disease
4个月前
已完结
Acarbose ameliorates podocyte injury and glomerular lesions in diabetic nephropathy through USP46 activation
4个月前
已完结
Exploring the nephroprotective effects of combined finerenone and exenatide therapy in diabetic nephropathy
4个月前
已完结
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial
7个月前
已关闭
Two drugs are better than one to start T2DM therapy
8个月前
已完结
Superior efficacy of empagliflozin and finerenone combination therapy versus monotherapy in patients with CKD and T2DM
8个月前
已关闭
Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review
8个月前
已完结
皖公网安备34019202002308
